Literature DB >> 19936965

Measurement limit of quality-of-life questionnaires in psychiatric settings.

Takeshi Nishiyama1, Norio Ozaki.   

Abstract

PURPOSE: The extent to which psychiatric patients with a broad spectrum of disability can validly self-report on their quality of life (QOL) remains unknown. Therefore, the aim of this study was to clarify the measurement limit of a QOL questionnaire in psychiatric settings.
METHODS: We examined this issue by assessing data quality, reliability, and validity of the MOS 36-Item Short-Form Health Survey (SF-36) in 137 chronically mentally ill inpatients. We also attempted to identify the impact of cognitive impairment on the validity of the SF-36 and ascertain the points throughout the continuum of cognitive functioning at which self-reported data become compromised.
RESULTS: Cognitive functioning was a major determinant of the data quality, and the psychometric properties of this instrument were marginally acceptable only in patients with Mini-Mental State Examination scores of 28 or higher.
CONCLUSIONS: Measuring QOL reliably and validly through self-report may be possible in psychiatric patients with only very slight cognitive impairment. Therefore, interviewer-administered instruments that measure QOL may be preferable to questionnaires in psychiatric settings.

Entities:  

Mesh:

Year:  2009        PMID: 19936965     DOI: 10.1007/s11136-009-9556-1

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  26 in total

1.  Convergent and discriminant validation by the multitrait-multimethod matrix.

Authors:  D T CAMPBELL; D W FISKE
Journal:  Psychol Bull       Date:  1959-03       Impact factor: 17.737

2.  Long-stay patients in a psychiatric hospital in Southern Brazil.

Authors:  Marcelo Pio de Almeida Fleck; Luciane Wagner; Mário Wagner; Miriam Dias
Journal:  Rev Saude Publica       Date:  2007-02       Impact factor: 2.106

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  Measuring general health status in dementia: practical and methodological issues in using the SF-36.

Authors:  J L Novella; C Jochum; J Ankri; I Morrone; D Jolly; F Blanchard
Journal:  Aging (Milano)       Date:  2001-10

5.  Reliability, validity, and application of the medical outcomes study 36-item short-form health survey (SF-36) in schizophrenic patients treated with olanzapine versus haloperidol.

Authors:  S L Tunis; T W Croghan; D K Heilman; B M Johnstone; R L Obenchain
Journal:  Med Care       Date:  1999-07       Impact factor: 2.983

6.  Nithsdale Schizophrenia Surveys. 20. Cognitive function in a catchment-area-based population of patients with schizophrenia.

Authors:  C Kelly; V Sharkey; G Morrison; J Allardyce; R G McCreadie
Journal:  Br J Psychiatry       Date:  2000-10       Impact factor: 9.319

7.  Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology.

Authors:  M Atkinson; S Zibin; H Chuang
Journal:  Am J Psychiatry       Date:  1997-01       Impact factor: 18.112

8.  Disability, outcome and case-mix in acute psychiatric in-patient units.

Authors:  B Boot; W Hall; G Andrews
Journal:  Br J Psychiatry       Date:  1997-09       Impact factor: 9.319

9.  The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

Authors:  C A McHorney; J E Ware; A E Raczek
Journal:  Med Care       Date:  1993-03       Impact factor: 2.983

10.  Feasibility, acceptability and internal consistency reliability of the nottingham health profile in dementia patients.

Authors:  Florence Bureau-Chalot; Jean-Luc Novella; Damien Jolly; Joël Ankri; Francis Guillemin; François Blanchard
Journal:  Gerontology       Date:  2002 Jul-Aug       Impact factor: 5.140

View more
  3 in total

1.  Relevance of quality of life assessment for multiple sclerosis patients with memory impairment.

Authors:  Karine Baumstarck; Françoise Reuter; Mohamed Boucekine; Valérie Aghababian; Irina Klemina; Anderson Loundou; Jean Pelletier; Pascal Auquier
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

2.  Is the concept of quality of life relevant for multiple sclerosis patients with cognitive impairment? Preliminary results of a cross-sectional study.

Authors:  Karine Baumstarck; Jean Pelletier; Valérie Aghababian; Françoise Reuter; Irina Klemina; Julie Berbis; Anderson Loundou; Pascal Auquier
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

3.  Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices.

Authors:  Karine Baumstarck; Mohamed Boucekine; Laurent Boyer; Valérie Aghababian; Nathalie Parola; Françoise Reuter; Anderson Loundou; Christophe Lançon; Jean Pelletier; Pascal Auquier
Journal:  BMC Neurol       Date:  2014-04-08       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.